https://www.europesays.com/ie/732640/ Scientists just gave the powerhouses of our cells a high-tech upgrade #Éire #IE #Ireland #PersonalizedMedicine;DiseasesAndConditions;Pharmacology;WorkplaceHealth;Today'sHealthcare;HealthyAging;MedicalTopics;HumanBiology #Science
#personalizedmedicine — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #personalizedmedicine, aggregated by home.social.
-
https://www.europesays.com/ie/732406/ Scientists just gave the powerhouses of our cells a high-tech upgrade #Éire #IE #Ireland #PersonalizedMedicine;DiseasesAndConditions;Pharmacology;WorkplaceHealth;Today'sHealthcare;HealthyAging;MedicalTopics;HumanBiology #Science
-
https://www.europesays.com/dk/183904/ Scientists discover 5 hidden brain patterns behind depression #Finland #helsinki #PersonalizedMedicine;MentalHealthResearch;DiseasesAndConditions;Today'sHealthcare;MentalHealth;Depression;Intelligence;Stress
-
Bowel cancer “melted away” after immunotherapy, then stayed away
Patients with a particular form of bowel cancer remained free of recurrence for almost three years after receiving…
#NewsBeep #News #Health #CA #Canada #PersonalizedMedicine;Today'sHealthcare;Pharmacology;Pharmaceuticals;DiseasesandConditions;WorkplaceHealth;ImmuneSystem;PatientEducationandCounseling
https://www.newsbeep.com/ca/928606/ -
DATE: October 1, 2026 at 04:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: New study identifies four unique migraine phenotypes using artificial intelligence
A recent study found that artificial intelligence algorithms can accurately identify people with migraines without relying on any information about their head pain. Published in the journal Neurology, the research suggests that migraines exist on a spectrum of distinct biological and clinical subtypes rather than as a single condition.
Migraine is a common neurological condition characterized by intense, pulsating head pain often accompanied by nausea and sensitivity to light and sound. The condition frequently causes severe disruptions to daily life, limiting a person’s ability to work or engage in regular activities. The medical field currently diagnoses the disorder based entirely on a patient’s self-reported symptoms during clinical visits.
There are no established biological markers, such as a blood test or a specialized brain scan, to definitively confirm a migraine diagnosis. Because symptoms and treatment responses vary widely among patients, medical professionals debate whether migraine is a single uniform disease. Some researchers suspect it is a spectrum of related syndromes.
These varying syndromes likely result from combinations of genetic vulnerabilities and environmental factors. Previous research into the genetics of migraine has identified many associated DNA variants. However, adding up these individual genetic risks only explains a small portion of how the condition is inherited.
This gap in understanding suggests that genetic factors might interact with each other and with environmental triggers in ways that simple statistical models cannot easily capture. Antonios Danelakis, a researcher at the Norwegian University of Science and Technology, led a team to explore these hidden patterns in patient data. They hypothesized that advanced artificial intelligence could capture the full biological footprint of the condition.
To investigate this, the researchers conducted a large study using data from the Trøndelag Health Study in Norway. This massive public health initiative gathered extensive information through physical examinations, blood samples, and self-administered questionnaires. This initial analysis included 43,197 individuals who had provided genetic samples and completed the required health surveys. The participants were classified as either having migraines or being headache-free based on traditional medical criteria.
The team built predictive machine learning models to differentiate the migraine sufferers from the healthy controls. They trained these algorithms using genetic data and general clinical information. This clinical data included details about sleep patterns, cardiovascular health, mental health, socioeconomic status, and regular medication use.
The researchers intentionally excluded any data about the participants’ actual headaches from the computer models. They wanted to test whether the algorithms could detect a migraine diagnosis entirely through other biological and lifestyle markers. The algorithms were trained on one portion of the participants and then evaluated on a separate, unseen group to verify their accuracy.
A specific type of machine learning algorithm performed the best on the test group. The algorithm successfully identified individuals with migraines with a high degree of accuracy. This success indicated that the condition is associated with a wide constellation of clinical and biological markers outside of the head.
The researchers analyzed the algorithm to see which features were most predictive of a migraine diagnosis. The top factors included age, biological sex, neck pain, and nausea. Other highly predictive factors were sleepiness, blood pressure variations, and self-reported mental health status.
Adding genetic data to the clinical data provided only a marginal improvement in the algorithm’s accuracy. The researchers noted that rich clinical data likely already captures the physical manifestations of a person’s genetic risk. Because the clinical data reflects the downstream effects of DNA, the genetic information itself became slightly redundant for diagnostic purposes.
In the second phase of the research, the team conducted another large study focusing on 12,185 individuals who reported experiencing headaches. This time, they used unsupervised machine learning models. Instead of giving the algorithm traditional medical definitions to look for, they allowed the computer to find natural groupings in the data.
The researchers fed the algorithm the participants’ specific headache characteristics, along with the most predictive general health features identified in the first analysis. They used clustering algorithms to see how the patients grouped together mathematically based on shared data points. To better understand these mathematical groupings, the team used an advanced dimensional reduction technique that translated the highly complex data into two-dimensional visual maps.
The unsupervised models divided the participants into two main clusters. The first cluster contained 1,425 individuals, and the algorithm grouped them based on shared traits. When the researchers checked this group against traditional medical guidelines, they found that nearly all of these individuals met the official criteria for a migraine diagnosis.
The second cluster contained 10,760 individuals. Most of the people in this larger group (71%) had non-migraine headaches. This division demonstrated that the artificial intelligence could naturally separate migraine sufferers from other headache patients without being explicitly taught the medical rules.
The researchers then instructed the algorithm to break the migraine cluster down into smaller subgroups. They based this subclustering on the general health features like neck pain and mental health. This process revealed four distinct subtypes of migraine sufferers.
The first subtype consisted entirely of men. The second subtype was characterized by prominent neck pain and an absence of general stomach issues, possibly representing patients whose migraines have a strong connection to neck tension.
The third subtype featured widespread muscle and bone pain, combined with lower self-reported health and higher levels of anxiety and depression. The researchers suggested this group might represent a phenotype where the nervous system is highly reactive to pain. The fourth subtype fit the classic picture of a pulsating migraine but lacked the psychological and widespread physical pain symptoms seen in the third group.
To analyze genetic profiles, the team conducted genome-wide association studies comparing the data-driven migraine group with those labeled as having migraine by traditional criteria. This process scanned genetic variants across tens of thousands of participants to find DNA patterns linked to each group, and found a high degree of overlap in the identified risk loci. When the team compared genetic risk scores across the four subgroups, the machine learning-based genetic risk scores were distinctly different across the subclusters, supporting the idea that these clinical subgroups reflect genuine biological differences.
The study relied on self-reported questionnaires to determine the participants’ initial medical status. Self-reporting can lead to misclassification if participants misremember their symptoms or misunderstand the questions. For instance, people with infrequent migraines might have incorrectly answered negatively to questions about having headaches within the past year, falsely placing them in the healthy control group.
The clinical data was collected between 1995 and 2008. Lifestyle behaviors, mental health trends, and typical sleep patterns have likely shifted since that time, meaning the data might not perfectly reflect a modern population. The genotyping technology used during those years was also less comprehensive than modern laboratory platforms.
The identified relationships between clinical features and migraine subtypes are correlations. The findings do not mean that these general health features directly cause migraines, only that they tend to occur together in specific patterns. The researchers noted that these models need to be validated in entirely different populations before being used in standard medical practice.
Future research should investigate whether these newly identified migraine subtypes respond differently to specific medications. A deeper understanding of these categories could help doctors prescribe targeted treatments rather than relying on a trial-and-error approach. Scientists could also use wearable devices and smartphone applications to track patient symptoms in real time, providing even more detailed data for future algorithms.
The study, “Machine Diagnostics and Machine Phenotyping of Migraine: A HUNT Study,” was authored by Antonios Danelakis, Håkon Kvisle Abildsnes, Fahim Faisal, Marte-Helene Bjørk, Dominic Giles, Knut Hagen, Tjaṧa Kumelj, Manjit Matharu, Parashkev Nachev, Erling Tronvik, Bendik S. Winsvold, and Anker Stubberud.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #MigraineSubtypes #AIMachineLearning #NeurologyResearch #MigrainePhenotypes #PersonalizedMedicine #HeadacheScience #GeneticsAndMigraine #WearableHealth #ClinicalDataInsights #HUNTStudy
-
DATE: September 29, 2026 at 08:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain structure linked to how well patients respond to an antidepressant, small study finds
An exploratory study of people with major depressive disorder found that the shape and structure of several regions of the brain’s outer layer, measured before treatment began, were associated with how much patients’ symptoms improved over about eight weeks of taking the antidepressant vortioxetine. The regions included areas of the frontal lobes involved in emotion regulation and planning, visual areas at the back of the brain, and the insula, a region involved in emotional awareness and in sensing the body’s internal state. The paper was published in BMC Psychiatry.
Major depressive disorder (MDD) is a common and often recurring psychiatric condition that can substantially impair everyday functioning and quality of life. Although many antidepressant medications are available, only about one-third of patients achieve remission, meaning their symptoms largely resolve, after their first treatment. People differ considerably in how well they respond to antidepressants, making it difficult to know in advance which treatment will work best for a particular patient.
Researchers are therefore trying to identify characteristics that might help predict treatment response and support more personalized approaches to care. Clinical factors such as the initial severity of depression, duration of illness, anxiety symptoms, and early improvement during treatment have all been linked to later outcomes.
Yingna Li and colleagues at Beijing HuiLongGuan Hospital in China used high-resolution structural magnetic resonance imaging, which captures the brain’s anatomy rather than its activity, along with a technique called surface-based morphometry, to explore whether features of the cortex, the brain’s wrinkled outer layer, could help predict improvement in depressive symptoms after antidepressant treatment.
They also wanted to know whether cognitive improvement is associated with these brain characteristics. The researchers were particularly interested in memory performance. They noted that cognitive problems are common in depression and sometimes persist even after mood symptoms improve. Because cognitive impairments can negatively affect the lives of depressed individuals, finding ways to predict their recovery is also an important goal.
The researchers initially recruited 34 adults between the ages of 18 and 50 who met diagnostic criteria for major depressive disorder, along with 26 healthy individuals for comparison who were matched with the depressed participants on age and sex. All of the patients had experienced at least one previous depressive episode and had not taken antidepressants in the eight weeks before enrolling. Four participants with depression and three healthy participants were excluded because of poor-quality brain scans, mostly due to excessive head movement, and 10 more participants with depression did not return for the follow-up visit. As a result, all analyses were performed on 22 participants with depression and 21 healthy participants.
All participants with depression took a daily 10-milligram dose of vortioxetine. Before and after treatment, they were assessed with the 17-item Hamilton Rating Scale for Depression and the Hamilton Anxiety Rating Scale, two clinician-administered measures of symptom severity, and completed the Repeatable Battery for the Assessment of Neuropsychological Status, a set of brief tests of memory, attention, language, and visual-spatial skills. On average, participants’ depression scores fell from about 27 to about 8 over the course of treatment.
Participants with depression had brain scans at the start of the study and again about eight weeks later, after treatment, while healthy participants were scanned once. However, this study analyzed only the scans taken at the start, because the goal was to see whether brain features measured before treatment were linked to later improvement.
The researchers used these scans to measure four features of the cortical surface: cortical thickness; the gyrification index, which reflects how much of the cortex is tucked into folds rather than exposed at the surface; sulcus depth, the depth of the grooves between folds; and fractal dimension, a measure of how complex and irregular the folding pattern is.
Compared with healthy participants, those with depression showed less folding in the right insula.
Among participants with depression, higher fractal dimension, indicating more complex folding, in the left superior frontal cortex, the right rostral middle frontal cortex, and the right lateral occipital cortex was associated with greater symptom improvement. The two frontal regions are part of the prefrontal cortex, which is involved in emotion regulation and executive control, while the lateral occipital cortex is a visual area. Greater cortical thickness in the insula on both sides of the brain and in the left pericalcarine cortex, part of the primary visual cortex, was also linked to greater improvement.
In contrast, lower fractal dimension in the left cuneus, another visual region, and less folding (a lower gyrification index) in the left lateral occipital cortex were associated with greater improvement. Several of these associations, including those involving the insula and the right lateral occipital cortex, concerned improvement in anxiety scores rather than depression scores.
On the cognitive side, shallower grooves (lower sulcus depth) in the left lateral occipital cortex were associated with greater improvement in delayed memory, the ability to recall information after some time has passed since it was first learned.
To check whether these associations might hold up beyond the specific people studied, the researchers used a technique called leave-one-out cross-validation, in which a statistical model is built using all but one participant and then used to predict the remaining participant’s outcome, with the process repeated for everyone.
In these tests, which also accounted for participants’ age and sex, fractal dimension of the left cuneus was associated with changes in depression scores, though this result was only borderline statistically significant, and fractal dimension of the left superior frontal cortex was associated with changes in anxiety scores. The link between sulcus depth in the left lateral occipital cortex and delayed memory did not reach statistical significance in this test.
“Baseline cortical morphometric features were associated with clinical and cognitive changes following antidepressant treatment in MDD [major depressive disorder],” the study authors concluded. They also added that “these findings are preliminary and should be interpreted with caution, pending replication in independent cohorts.”
The study contributes to the scientific understanding of the links between the brain’s structure and the course of depression during treatment. However, it should be noted that the study was conducted on a very small sample of participants, and the authors acknowledge that because many separate analyses were run, some associations may be false positives and their strength is likely overestimated. Results of larger studies may differ.
All patients received the same drug, so the findings may not apply to other antidepressants, and participants were relatively young. There was also no placebo group, so the study cannot separate improvement caused by the medication from improvement that might have happened for other reasons. Additionally, the design of the study does not allow any causal inferences to be derived from the results.
The paper “Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder” was authored by Yingna Li, Shuping Tian, Siyan Zan, Ruonan Du, Wenzhou Liang, Liying Zhao, and Zhiren Wang.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #BrainStructure #DepressionTreatment #AntidepressantResponse #Vortioxetine #CorticalMorphometry #FrontalLobe #Insula #VisualCortex #Neuroimaging #PersonalizedMedicine
-
DATE: September 27, 2026 at 06:49AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Why rheumatoid arthritis pain may persist even when inflammation is under control
URL: https://www.sciencedaily.com/releases/2026/09/260925093208.htm
Pain and fatigue in rheumatoid arthritis can persist even after inflammation improves, with depression, poor sleep, obesity, smoking, and chronic pain potentially helping sustain symptoms. Researchers say identifying these hidden drivers could prevent unnecessary medication changes and lead to more personalized treatment.
URL: https://www.sciencedaily.com/releases/2026/09/260925093208.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #RheumatoidArthritis #RApain #ChronicPain #InflammationControl #PainPersistence #RAfatigue #MentalHealthRA #SleepQuality #PersonalizedMedicine #RAresearch
-
https://www.europesays.com/ie/706893/ Don’t toss cannabis leaves: They may contain rare compounds with medical potential #Éire #IE #Ireland #PersonalizedMedicine;Today'sHealthcare;Nutrition;Pharmaceuticals;NewSpecies;BeerAndWine;EndangeredPlants;EndangeredAnimals #Science
-
https://www.europesays.com/ie/706709/ Don’t toss cannabis leaves: They may contain rare compounds with medical potential #Éire #IE #Ireland #PersonalizedMedicine;Today'sHealthcare;Nutrition;Pharmaceuticals;NewSpecies;BeerAndWine;EndangeredPlants;EndangeredAnimals #Science
-
https://www.europesays.com/pt/526093/ 5 subtipos de doença hepática comum são descobertos — incluindo formas genéticas de progressão rápida #AllJournalNews #cancer #CardiovascularHealth #diabetes #Health #LiverDisease #MayoClinic #MayoClinic;DrShulanTian;DrKonstantinosLazaridis;DrEricKlee;doençaHepática;câncerDeFígado;cirrose;transplante #Nature(journal) #Newswise #obesity #PersonalizedMedicine #Portugal #PT #PublicHealth #Saúde
-
https://www.europesays.com/ie/689229/ Tiny cell “antennas” may help explain why some babies are born with heart defects #Éire #IE #Ireland #PersonalizedMedicine;DiseasesAndConditions;PatientEducationAndCounseling;WorkplaceHealth;Today'sHealthcare;Cancer;PregnancyAndChildbirth;HealthyAging #Science
-
Scientists find a new layer of Alzheimer’s hidden in the genome
Researchers at Carnegie Mellon University’s School of Computer Science, the University of Pittsburgh School of Medicine and the…
#NewsBeep #News #Health #CA #Canada #PersonalizedMedicine;AlternativeMedicine;ImmuneSystem;NervousSystem;Dementia;Intelligence;Neuroscience;Alzheimer's
https://www.newsbeep.com/ca/894307/ -
https://www.europesays.com/ie/686763/ Scientists find a new layer of Alzheimer’s hidden in the genome #Éire #Health #IE #Ireland #PersonalizedMedicine;AlternativeMedicine;ImmuneSystem;NervousSystem;Dementia;Intelligence;Neuroscience;Alzheimer's
-
🔬 What if a tumor sample could serve as its own reference?
🔗 Reference-Free Microsatellite Instability Detection from Tumor Sequencing Using Intrasample Variability Modeling. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0219
📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj
#MicrosatelliteInstability #MSI #CancerGenomics #NextGenerationSequencing #ComputationalBiology #Genomics #PersonalizedMedicine #Oncology #Biomarkers #PrecisionMedicine
-
https://www.europesays.com/es/746444/ Científicos descubren un sistema de señalización del microbioma que podría abrir nuevas vías para tratar la constipación relacionada con el SII #AllJournalNews #ClinicalTrials #DigestiveDisorders #ES #España #Health #healthcare #InvestigaciónDeMayoClinic;microbiomaIntestinal;Microbioma;síndromeDelIntestinoIrritable #MayoClinic #Microbiome #Newswise #PersonalizedMedicine #Salud #Spain
-
https://www.europesays.com/ch/125216/ Digital Solutions Will Revolutionize Healthcare #cancer #ClinicalTrials #DiagnosticTests #EquitaleAccess #GDP #HealthcareSystems #investment #LatinAmerica #patients #PersonalizedMedicine #policies #qualitative #Roche #RolfHoenger #SustainableSystems #WHO
-
🚀🎉 Behold, RonanRX, the groundbreaking solution to the problem you didn’t know you had: one-size-fits-none medication! Now, with just a ✨simple✨ text, you can finally get personalized drugs, because who knew your body wasn’t a generic template? 🙄 Let’s just hope their text messages are as personalized as their peptides. 📱💊
https://ronanrx.com/ #personalizedmedicine #medicationinnovation #healthtech #drugdelivery #HackerNews #ngated -
A cancer therapy put severe rheumatoid arthritis into remission
Immunotherapies such as CAR T-cell therapy were originally developed mainly to fight cancer. But scientists are now investigating…
#NewsBeep #News #Health #AU #Australia #PersonalizedMedicine;Pharmacology;Allergy;Leukemia;Pharmaceuticals;Today'sHealthcare;DiseasesandConditions;Lymphoma
https://www.newsbeep.com/au/873620/ -
https://www.europesays.com/ie/663202/ A cancer therapy put severe rheumatoid arthritis into remission #Éire #Health #IE #Ireland #PersonalizedMedicine;Pharmacology;Allergy;Leukemia;Pharmaceuticals;Today'sHealthcare;DiseasesAndConditions;Lymphoma
-
A cancer therapy put severe rheumatoid arthritis into remission
Immunotherapies such as CAR T-cell therapy were originally developed mainly to fight cancer. But scientists are now investigating…
#NewsBeep #News #Health #AU #Australia #PersonalizedMedicine;Pharmacology;Allergy;Leukemia;Pharmaceuticals;Today'sHealthcare;DiseasesandConditions;Lymphoma
https://www.newsbeep.com/au/873444/ -
https://www.europesays.com/ie/663046/ A cancer therapy put severe rheumatoid arthritis into remission #Éire #Health #IE #Ireland #PersonalizedMedicine;Pharmacology;Allergy;Leukemia;Pharmaceuticals;Today'sHealthcare;DiseasesAndConditions;Lymphoma
-
https://www.europesays.com/ch/121360/ FDA Expands Approval of Roche HER2 Tests for Gastroesophageal Cancer #adenocarcinoma #CancerDiagnostics #ClinicalLaboratory #CompanionDiagnostics #DiagnosticTesting #EsophagealCancer #FDAApproval #GastroesophagealCancer #HER2+ #immunohistochemistry #ISHAssay #JazzPharmaceuticals #MetastaticCancer #Oncology #pathology #PersonalizedMedicine #Roche #TargetedTherapy #zanidatamab #ZIIHERA
-
https://www.europesays.com/ie/655110/ Depression may shut down the brain’s ability to make new neurons #Éire #Health #IE #Ireland #PersonalizedMedicine;DiseasesAndConditions;HealthyAging;Genes;SocialPsychology;Memory;MentalHealth;Psychology
-
A hidden “on switch” in human DNA has finally been decoded
Healthy growth and development depend on tens of thousands of genes being switched on at the right time…
#NewsBeep #News #Science #GB #PersonalizedMedicine;DiseasesandConditions;WorkplaceHealth;BiotechnologyandBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence #UK #UnitedKingdom
https://www.newsbeep.com/uk/747740/ -
A hidden “on switch” in human DNA has finally been decoded
Healthy growth and development depend on tens of thousands of genes being switched on at the right time…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Science #PersonalizedMedicine;DiseasesandConditions;WorkplaceHealth;BiotechnologyandBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence
https://www.newsbeep.com/us/823766/ -
https://www.europesays.com/uk/1165743/ A hidden “on switch” in human DNA has finally been decoded #PersonalizedMedicine;DiseasesAndConditions;WorkplaceHealth;BiotechnologyAndBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence #Science #UK #UnitedKingdom
-
A hidden “on switch” in human DNA has finally been decoded
Healthy growth and development depend on tens of thousands of genes being switched on at the right time…
#NewsBeep #News #Science #CA #Canada #PersonalizedMedicine;DiseasesandConditions;WorkplaceHealth;BiotechnologyandBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence
https://www.newsbeep.com/ca/868795/ -
https://www.europesays.com/ie/652559/ A hidden “on switch” in human DNA has finally been decoded #AI #ArtificialIntelligence #ArtificialIntelligence #Éire #IE #Ireland #PersonalizedMedicine;DiseasesAndConditions;WorkplaceHealth;BiotechnologyAndBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence #Technology
-
https://www.europesays.com/3211144/ A hidden “on switch” in human DNA has finally been decoded #AI #ArtificialIntelligence #PersonalizedMedicine;DiseasesAndConditions;WorkplaceHealth;BiotechnologyAndBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence
-
A hidden “on switch” in human DNA has finally been decoded https://www.byteseu.com/2300999/ #AI #ArtificialIntelligence #PersonalizedMedicine;DiseasesAndConditions;WorkplaceHealth;BiotechnologyAndBioengineering;DevelopmentalBiology;MolecularBiology;ComputerModeling;Hacking;ArtificialIntelligence
-
And voila! #PersonalizedMedicine FTW!
Big deal. Really big deal. 12 years ago my family left our home & embarked with me on a journey to, among other things, help researchers kick #cancers ass by driving down the cost and increasing the speed of #DNASequencing. This is rewarding news.
#mRNA #vaccine
https://www.reuters.com/legal/litigation/moderna-merck-breakthrough-could-usher-wave-cancer-vaccines-2026-08-19/ -
https://www.europesays.com/ie/646678/ More than 1,000 genetic switches reveal why female immunity is different #Éire #Health #IE #Ireland #PersonalizedMedicine;WorkplaceHealth;JointPain;Fertility;DiseasesAndConditions;PainControl;Lupus;PregnancyAndChildbirth
-
A personalized mRNA cancer vaccine has succeeded in a major Phase 3 melanoma trial.
The Moderna-Merck treatment is created using mutations found in each patient’s own tumor and is given alongside Keytruda.
The 1,137-patient trial showed significant improvements in preventing melanoma from returning and spreading.
It is not approved yet, and the full Phase 3 numbers still need to be released.
https://thenewsink.com/personalized-cancer-vaccine-breakthrough/
#CancerVaccine #Melanoma #CancerResearch #PersonalizedMedicine #TheNewsInk
-
Circadian Oncology: Timing, Cancer Treatment, and Patient Outcomes
IntroductionCircadian regulation in cancer biologyThe promise and challenges of cancer chronotherapyThe future of circadian medicine in cancer careReferencesFurther…
#NewsBeep #News #Health #AU #Australia #CancerChronotherapy #CancerTreatment #Chronomedicine #CircadianOncology #CircadianRhythms #oncology #PersonalizedMedicine #PrecisionOncology
https://www.newsbeep.com/au/853333/ -
https://www.europesays.com/ie/634131/ Circadian Oncology: Timing, Cancer Treatment, and Patient Outcomes #CancerChronotherapy #CancerTreatment #Chronomedicine #CircadianOncology #CircadianRhythms #Éire #Health #IE #Ireland #oncology #PersonalizedMedicine #PrecisionOncology
-
https://www.europesays.com/britain/99268/ Personalis NeXT Personal Dx Cancer Test Gains UKCA Mark for Great Britain #BiomarkerTesting #biopharma #Britain #CancerDetection #CirculatingTumorDNA #ClinicalDiagnostics #ClinicalTrials #GreatBritain #LaboratoryTechnology #LiquidBiopsy #MinimalResidualDisease #Oncology #PersonalizedMedicine #ProductCommercialization #RegulatoryApproval #UKCAMarking
-
https://www.europesays.com/uk/1135968/ Personalis NeXT Personal Dx Cancer Test Gains UKCA Mark for Great Britain #BiomarkerTesting #biopharma #Britain #CancerDetection #CirculatingTumorDNA #ClinicalDiagnostics #ClinicalTrials #England #GreatBritain #LaboratoryTechnology #LiquidBiopsy #MinimalResidualDisease #NorthernIreland #oncology #PersonalizedMedicine #ProductCommercialization #RegulatoryApproval #Scotland #UK #UKCAMarking #UnitedKingdom #Wales
-
Learn why 3D bioprinting is revolutionizing personalized medicine and organ transplants, offering hope for patient-specific treatments and future healthcare.
#3DBioprinting #PersonalizedMedicine #OrganTransplants
https://www.scientificworldinfo.com/2026/05/why-is-3d-bioprinting-future-of-personalized-medicine.html -
💊 "Mistero svelato: scoperto perché l'Ozempic non funziona per tutti. Un passo avanti verso una medicina più personalizzata! #ScienzaMedica #PersonalizedMedicine"
🔗 https://www.tomshw.it/scienze/ozempic-scoperto-perche-non-funziona-per-tutti-2026-04-13
-
Meta’s New AI Asked for My Raw Health Data—and Gave Me Terrible Advice
-
Meta’s New AI Asked for My Raw Health Data—and Gave Me Terrible Advice
-
Final Year Projects with Publication Support from BioResire!
Drug Discovery, Nanotech, NGS in Personalized Medicine—cert + e-book.
Join students: https://whatsapp.com/channel/0029Vb5u2Tp77qVTb1D7bu3r#FinalYearProject #BioResire #BiotechProjects #PublicationSupport #DrugDiscovery #Nanotech #NGS #PersonalizedMedicine #LifeSciences #Biotechnology #MScProjects #BScProjects #ResearchProjects #Bioinformatics #BioResireStudents #STEMProjects #IndiaResearch #ProjectPublication #WhatsAppCommunity #BioProjects
-
🧬 Is it possible to make whole-genome sequencing practical for everyday clinical care?
🔗 GenRiskPro: A Comprehensive Whole-Genome Sequencing Analysis Platform for Clinical and Wellness Applications. https://spj.science.org/doi/epdf/10.34133/csbj.0011
📚 CSBJ (Smart Hospital Section) - A Science Partner Journal: https://spj.science.org/page/csbj/for-authors#smarthospital
#Genomics #PrecisionMedicine #WholeGenomeSequencing #DigitalHealth #PersonalizedMedicine
-
Pipeline release! nf-core/hlatyping v2.2.0 - 2.2.0 - Holocron!
Precision HLA typing from next-generation sequencing data
Please see the changelog: https://github.com/nf-core/hlatyping/releases/tag/2.2.0#dna #hla #hlatyping #immunology #optitype #personalizedmedicine #rna #nfcore #openscience #nextflow #bioinformatics
-
ATTENTION #CANCERPATIENTS & #oncologists
Why settle for a "one-size-fits-all" treatment when your cancer's genetic signature is unique to you? Personalized oncology is reducing trial-and-error, minimizing toxic side effects, and targeting treatments to your specific biology. Learn why personalized care is the future on Blogspot:
https://soniyalopez2025.blogspot.com/2026/01/top-benefits-of-personalized-oncology.html
#PrecisionOncology #PersonalizedMedicine #PatientAdvocacy #CancerKillerCells #HealthEquality
-
The future will be personalized, precise & continuously monitored. 💊📡
know more:https://zurl.co/T4nZD
#Smidmart #TrackAndTrace #PersonalizedMedicine #RFID #SmartHealthcare #FutureOfCare #HealthTech #IIoT -
Genomics Test: What is a genomics test?
https://vaartha.com/health/what-is-a-genomics-test/609778/
#GenomicsTest #Genomics #WhatIsGenomics #DNATest #GeneticTesting #GenomeTesting #HealthTest #GenomicScience #MedicalGenetics #DNASequencing #PersonalizedMedicine #GeneticHealth #GeneTest #GenomicsExplained #HealthCheck #Biotech #GenomeAnalysis #GeneticInfo #ScienceExplained #HealthAwareness -
3D-printed carotid artery-on-chips for personalized thrombosis investigation
https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202508890
#HackerNews #3Dprinting #personalizedmedicine #thrombosis #biomaterials #healthtech
-
🧬 Cancer vaccines aren’t science fiction anymore, they’re reshaping treatment in 2025.
From mRNA breakthroughs to personalized therapies, cancer vaccines are changing how doctors fight cancer. Our latest guide explores how these innovations are improving survival, reducing relapse, and offering new hope to patients and families.
Explore more👉 https://blog.banishcancer.org/updates-on-cancer-vaccines-progress-and-perspectives-2025/
#CancerVaccines #Oncology #Immunotherapy #PersonalizedMedicine #MRNA #BanishCancer
-
🌍 Excited to announce HealthAI2026 – International Conference on Precision Medicine and AI Healthcare!
🔗healthai.pagesconferences.org/registration
#HealthAI2026 #PrecisionMedicine #AIHealthcare #PersonalizedMedicine #HealthTech @[email protected] @[email protected] @ucl @umn_infectiousdiseases @uniofexeter @indianauniv @mayoclinic @[email protected] @[email protected] @europe @czechrepublic @universitiesuk @uukintl @berlinup @uukintl @gdnuniversities @uniofyork @charlesuniprg
-
Antidepressants: physical side-effects vary depending on the drug type – new research
#Health #Antidepressants #MentalHealth #Healthcare #PersonalizedMedicine #SideEffects #Depression #Anxiety #Wellbeing #PatientCare #Medicine #BloodPressure #Cholesterol
https://the-14.com/antidepressants-physical-side-effects-vary-depending-on-the-drug-type-new-research/ -
DATE: October 02, 2025 at 05:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
.@MHRAgovuk jumps into #PersonalizedMedicine with the ‘preference zone’
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
🌍 HealthAI2026 | July 27–28, 2026 | Prague, Czech Republic
📧 [email protected]
🌐 healthai.pagesconferences.orgLet’s shape the future of medicine together!
#HealthAI2026 #PrecisionMedicine #AIHealthcare #HealthcareInnovation #MedicalResearch #FutureOfMedicine #DigitalHealth #GlobalHealth #MedTech #LifeSciences #HealthcareAI #AIInMedicine #MedicalInnovation #HealthTech #AIForHealthcare #PersonalizedMedicine #Genomics #Bioinformatics #HealthcareSummit #NextGenHealthcare
-
HealthAI2026 | July 27–28, 2026 | Prague, Czech Republic 🚀
🌐 healthai.pagesconferences.org
#HealthAI2026 #PrecisionMedicine #AIHealthcare #HealthcareInnovation #MedicalResearch #FutureOfMedicine #DigitalHealth #GlobalHealth #MedTech #LifeSciences #HealthcareAI #AIInMedicine #MedicalInnovation #HealthTech #AIForHealthcare #PersonalizedMedicine #Genomics #Bioinformatics #HealthcareSummit #NextGenHealthcare #MedicalScience #FutureHealthcare #AIForHealth #HealthcareLeaders #ClinicalResearch
-
HealthAI2026 | Prague | July 27–28, 2026
🌐 healthai.pagesconferences.org
𝐁𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐰𝐡𝐞𝐫𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐦𝐞𝐞𝐭𝐬 𝐀𝐈 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧.
#HealthAI2026 #PrecisionMedicine #AIHealthcare #HealthcareInnovation #MedicalResearch #FutureOfMedicine #DigitalHealth #GlobalHealth #MedTech #LifeSciences #HealthcareAI #AIInMedicine #MedicalInnovation #HealthTech #AIForHealthcare #PersonalizedMedicine #Genomics #Bioinformatics #HealthcareSummit #NextGenHealthcare #MedicalScience #FutureHealthcare
-
Join us at the 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐨𝐧 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐀𝐈 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 (𝐇𝐞𝐚𝐥𝐭𝐡𝐀𝐈2026)
🌐 Register here: https://healthai.pagesconferences.org
📧 Contact: [email protected]
☎️ +91 6300291319#HealthAI2026 #PrecisionMedicine #AIHealthcare #FutureOfHealthcare #DigitalHealth #MedTech #HealthTech #LifeSciences #AIInHealthcare #Biotech #HealthcareInnovation #PersonalizedMedicine #HealthcareFuture #ArtificialIntelligence #DataScience #MachineLearning #DeepLearning #MedicalAI #SmartHealthcare
-
𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐨𝐧 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐀𝐈 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 (𝐇𝐞𝐚𝐥𝐭𝐡𝐀𝐈2026) happening on 𝐉𝐮𝐥𝐲 27–28, 2026, in 𝐏𝐫𝐚𝐠𝐮𝐞, 𝐂𝐳𝐞𝐜𝐡 𝐑𝐞𝐩𝐮𝐛𝐥𝐢𝐜.
📧 𝐄𝐦𝐚𝐢𝐥: [email protected]
#HealthAI2026 #PrecisionMedicine #AIHealthcare #FutureOfHealthcare #DigitalHealth #MedTech #HealthTech #LifeSciences #AIInHealthcare #Biotech #HealthcareInnovation #PersonalizedMedicine #HealthcareFuture #ArtificialIntelligence #DataScience #MachineLearning #DeepLearning #MedicalAI #SmartHealthcare #HealthcareTechnology
-
Mitochondria and Interoception: The Powerhouses Behind Your Feelings
#Interoception #BrainBodyConnection #Mitochondria #HealthScience #StressResponse #EnergyRegulation #Neuroscience #PersonalizedMedicine #BodyAwareness #HolisticHealth
